You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

Profile for Jordan Patent: 2791


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Jordan Patent: 2791

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 11, 2028 Phathom VOQUEZNA TRIPLE PAK amoxicillin; clarithromycin; vonoprazan fumarate
⤷  Get Started Free Aug 11, 2028 Phathom VOQUEZNA DUAL PAK amoxicillin; vonoprazan fumarate
⤷  Get Started Free Aug 11, 2028 Phathom VOQUEZNA vonoprazan fumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Jordan Drug Patent JO2791

Last updated: September 10, 2025


Introduction

The Jordanian patent JO2791 represents a significant intellectual property asset within the pharmaceutical sector. Understanding its scope, claims, and broader patent landscape is vital for stakeholders—including pharmaceutical companies, generic entrants, and legal professionals—seeking to navigate the patent’s enforceability, potential overlaps, and opportunities for innovation or licensing.

This analysis offers a comprehensive review of patent JO2791, focusing on its claims structure, scope, and its position within the global patent environment for similar drug molecules, formulations, and therapeutic indications.


Scope of Patent JO2791

Overview of Patent Scope

Patent JO2791 encompasses a specific therapeutic entity, formulation, or method of use, based on the detailed disclosure submitted by the patent holder. The scope is primarily defined by the claims section, which delineates the boundaries of patent protection.

In Jordan, as in most jurisdictions, patent scope hinges on claims clarity, novelty, and inventive step. The patent is designed to cover a particular drug or therapeutic approach, preventing third-party manufacturing or commercialization without license or permission.

Key Aspects of the Patent Scope

  • Chemical Composition: If the patent covers a novel compound, the scope will include the chemical formula, molecular structure, and possibly salts, isomers, or derivatives.
  • Method of Use: The scope may also extend to specific therapeutic indications, dosing regimens, or formulations that exploit the drug’s mechanism of action.
  • Formulation and Delivery: The patent might protect specific formulations—e.g., extended-release, combination drugs, or unique delivery systems.
  • Manufacturing Process: If claimed, methods of synthesis or purification may also fall within the scope.

The specific scope depends on the breadth of the claims—ranging from narrow, molecule-specific claims to broader class-based or use-based claims.


Claims Analysis

1. Main (Independent) Claims

The core claims define the broadest intellectual property rights conferred by JO2791. Typically, for pharmaceutical patents, the independent claim might focus on a specific chemical structure, e.g., a novel compound, or a particular therapeutic use.

For example:

  • A claim covering the chemical entity: "A compound of formula X, wherein R1, R2, R3 are..."
  • Or, a method of treating a disease using a compound of formula X.

The independent claims often set the foundation for subsequent dependent claims that add specificity.

2. Dependent Claims

Dependent claims narrow the scope, adding layers of specificity:

  • Particular substitutions on the core molecule
  • Specific dosing regimens
  • Formulations with excipients
  • Combination therapies

3. Claim Scope and Limitations

The scope and enforceability depend heavily on claim wording. Broad claims can offer strong protection but risk invalidation if challenged for lack of novelty or inventive step. Narrow claims can be easier to defend but provide limited protection.

4. Claims in the Context of Prior Art

The patent’s claims are likely crafted in response to existing prior art. Jordan’s patent office and accompanying patent literature may exhibit similar compounds or methods, emphasizing the patent’s novelty aspect. Claims that overlap with prior art may be challenged, especially if the claims are too broad or not sufficiently inventive.


Patent Landscape for Similar Drugs and Technologies

Global Patent Trends

The patent landscape for pharmaceutical molecules is highly competitive. For a drug covered by JO2791, there are often multiple patents worldwide, including:

  • Original Compound Patents: Covering the molecule itself, usually filed decades ago.
  • Use and Method Patents: Covering novel therapeutic applications.
  • Formulation and Manufacturing Patents: Protecting specific delivery systems or synthesis methods.

Major jurisdictions—such as the US, Europe, and China—likely feature patents with overlapping scope.

Key Patent Landscape Elements:

  • Patent Families: International patent families may have counterparts filed in Jordan, providing broad protection.
  • Patent Term and Extensions: Patent term adjustments or pediatric extensions can influence market exclusivity.
  • Patent Challenges and Litigation: Patent validity can be challenged based on prior art or inventive step.

Specific to Jordan

Jordan's patent law aligns with international standards (TRIPS compliant). Its patent examination process emphasizes novelty, inventive step, and industrial applicability. The patent landscape within Jordan may include local filings, regional patent collaborations, and international applications via PCT systems.

Overlap and Limitations

Any existing patents on similar compounds or uses could lead to:

  • Infringement Risks: If the claims of JO2791 overlap with earlier patents.
  • Freedom-to-Operate (FTO) Challenges: Especially if prior art in neighboring jurisdictions exists.
  • Potential for Licensing or Design-around: Companies may seek licenses or develop alternative compounds/formulations to circumvent patent claims.

Legal and Strategic Considerations

1. Patent Validity and Enforceability

The strength of JO2791 depends on robust claim drafting, thorough prior art searches, and prosecution history. Validity is susceptible to challenges based on prior art disclosures and obviousness arguments.

2. Competitive Positioning

If JO2791's claims are sufficiently narrow, competitors may develop alternative molecules or formulations. If broad, the patent can provide competitive dominance in Jordan and similar markets.

3. Opportunities for Patent Stratification

Potential exists to file follow-on patents, such as polymorph patents, combination patents, or method-of-use patents, to extend protection.

4. Monitoring and Enforcement

Active monitoring of local and regional patent filings can prevent infringement and foster licensing negotiations.


Conclusion: Positioning and Recommendations

  • Clear Identification of Claim Scope: Stakeholders must analyze the precise language of JO2791’s claims to assess enforceability and infringement risks.
  • Patent Landscape Mapping: Conduct comprehensive searches of similar compounds, methods, and formulations in Jordan and internationally.
  • Freedom-to-Operate Analysis: Evaluate potential overlaps with existing patents to avoid infringement.
  • Strategic Patent Filings: Consider filing continuation or divisional applications to broaden protection or cover follow-on innovations.
  • Legal Vigilance: Establish mechanisms for monitoring patent validity challenges, especially in jurisdictions with high patent litigations.

Key Takeaways

  • Scope Definition Is Crucial: The claims' breadth determines the patent’s strength, with narrow claims offering less protection but easier defensibility.
  • Landscape Mapping Is Essential: Understanding global patent trends helps predict potential challenges and licensing opportunities.
  • Protection Strategies Must Evolve: Continuous monitoring and follow-up patent filings can extend patent life and coverage.
  • Jurisdictional Specifics Matter: Jordanian patent law aligns with international standards but requires tailored strategies considering local legal nuances.
  • Proactive Legal and Commercial Approaches Are Critical: Engaging patent counsel for detailed freedom-to-operate and validity assessments optimizes market positioning.

FAQs

Q1: What is the typical scope of pharmaceutical patents like JO2791?
They generally cover the chemical compound itself, specific methods of use, formulation, and manufacturing processes, with scope defined precisely by claims.

Q2: How can I determine if JO2791’s claims are too broad or narrow?
Review the claims language, compare with prior art, and assess whether the claims encompass existing technologies or are sufficiently innovative.

Q3: What is the significance of the patent landscape in Jordan for JO2791?
It helps identify potential infringement risks, opportunities for licensing, and avenues for developing alternative formulations or uses.

Q4: How do global patents affect the enforceability of JO2791?
Similar patents worldwide can either reinforce protection or create opportunities for third-party challenges, influencing overall patent strength.

Q5: What strategies should a company pursue regarding JO2791?
Conduct thorough patent searches, monitor legal status, consider patent extensions or follow-on filings, and develop licensing or infringement prevention plans.


References

[1] World Intellectual Property Organization (WIPO): PatentScope Database.
[2] Jordan Amman International Patent Law Resources.
[3] European Patent Office (EPO): Guidelines for Examination.
[4] U.S. Patent and Trademark Office (USPTO): Patent Search Tools.
[5] International Patent Classification (IPC) codes related to pharmaceuticals.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.